The Comparative Efficacy of Ceftazidime–Avibactam with or without Aztreonam vs Polymyxins for Carbapenem-resistant Enterobacteriaceae Infections: A Prospective Observational Cohort Study
Author:
Publisher
Jaypee Brothers Medical Publishing
Subject
Critical Care and Intensive Care Medicine
Link
https://www.ijccm.org/doi/pdf/10.5005/jp-journals-10071-24577
Reference22 articles.
1. 1. Carbapenem-resistant Enterobacterales (CRE); Center for Disease Control and Prevention. Available from: https://www.cdc.gov/hai/organisms/cre/index.html.
2. 2. Mehrad B, Clark NM, Zhanel GG, Lynch III JP. Antimicrobial resistance in hospital-acquired Gram-negative bacterial infections. Chest 2015;147(5):1413–1421. DOI: 10.1378/chest.14-2171.
3. 3. Stewardson AJ, Marimuthu K, Sengupta S, Allignol A, El-Bouseary M, Carvalho MJ, et al. Effect of carbapenem resistance on outcomes of bloodstream infection caused by Enterobacteriaceae in low-income and middle-income countries (PANORAMA): A multinational prospective cohort study. Lancet Infect Dis 2019;19(6):601–610. DOI: 10.1016/S1473-3099(18)30792-8.
4. 4. Snyder BM, Montague BT, Anandan S, Madabhushi AG, Pragasam AK, Verghese VP, et al. Risk factors and epidemiologic predictors of bloodstream infections with New Delhi Metallo-b-lactamase (iNDM/i-1) producing Enterobacteriaceae. Epidemiol Infect 2019;147:e137. DOI: 10.1017/S0950268819000256.
5. 5. Patel G, Huprikar S, Factor SH, Jenkins SG, Calfee DP. Outcomes of carbapenem-resistant iKlebsiella pneumoniaee/i infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008;29(12):1099–1106. DOI: 10.1086/592412.
Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Eternal Hunt: Unravelling the Challenge of CRE, the Quest for Perfection Continues!;Indian Journal of Critical Care Medicine;2024-04-30
2. Management of CRE Infections: High Time for an RCT?;Indian Journal of Critical Care Medicine;2024-04-30
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3